What are the causes of pancytopenia in a patient with Human Immunodeficiency Virus (HIV) infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Pancytopenia in HIV Infection

The most common causes of pancytopenia in HIV-infected patients include direct HIV infection of bone marrow, opportunistic infections, medication side effects, and malignancies. Understanding these causes is crucial for proper management and improving patient outcomes.

Direct Effects of HIV Infection

  • HIV directly affects hematopoiesis through:
    • Infection of CD4+ T lymphocytes, monocytes/macrophages, and dendritic cells 1
    • Bone marrow suppression via abnormal cytokine expression 2
    • Alteration of the bone marrow microenvironment 2
    • Impaired B-cell antibody response 3

Medication-Related Causes

Antiretroviral Medications

  • Zidovudine (AZT) is a significant cause of pancytopenia:

    • Can cause bone marrow suppression leading to anemia, neutropenia, and thrombocytopenia 4
    • Pancytopenia with marrow hypoplasia has been reported as a post-marketing adverse effect 4
    • Significant anemia may require dose adjustment, discontinuation, or blood transfusions 4
  • Other antiretroviral medications:

    • Certain protease inhibitors and NNRTIs can affect bone marrow function
    • Drug interactions between antiretrovirals may exacerbate cytopenias 3

Opportunistic Infections

  • Common infectious causes:

    • Mycobacterium tuberculosis
    • Mycobacterium avium complex (MAC)
    • Pneumocystis jirovecii 5
    • Parvovirus B19 (can cause pure red cell aplasia) 6
    • Fungal infections (histoplasmosis, cryptococcosis)
    • Cytomegalovirus (CMV)
  • Infectious etiologies are associated with:

    • Fever
    • Splenomegaly
    • Low CD4+ counts 7

Malignancies

  • AIDS-defining malignancies:

    • Non-Hodgkin lymphoma
    • Primary CNS lymphoma
    • Invasive cervical cancer
  • Non-AIDS-defining malignancies:

    • Hodgkin lymphoma
    • Multiple myeloma
    • Leukemias
  • Malignant bone marrow infiltration is associated with:

    • Presence of adenopathies 7
    • Progressive weight loss
    • Night sweats

Other Causes

  • Immune-mediated destruction:

    • Immune thrombocytopenia 2
    • Autoimmune hemolytic anemia
  • Nutritional deficiencies:

    • Vitamin B12 deficiency
    • Folate deficiency
    • Iron deficiency
  • Bone marrow disorders:

    • Myelodysplastic syndrome
    • Aplastic anemia 2
  • Liver disease and hypersplenism:

    • Common in HIV patients with concurrent hepatitis B or C

Diagnostic Approach

  • Laboratory evaluation:

    • Complete blood count with differential
    • Reticulocyte count
    • Peripheral blood smear
    • HIV viral load and CD4+ count
    • Liver and kidney function tests
  • Bone marrow assessment:

    • Has high diagnostic yield (35.6% when including cultures) 7
    • Most valuable in patients with moderate/severe thrombocytopenia 7
    • Should include aspirate, biopsy, and cultures
  • Additional testing based on clinical suspicion:

    • Blood cultures
    • Serology for opportunistic infections
    • Parvovirus B19 PCR (serology may be unreliable due to insufficient seroconversion) 6
    • Imaging studies to evaluate for lymphadenopathy or splenomegaly

Management Considerations

  • Treating the underlying HIV infection is essential:

    • Optimal antiretroviral therapy can reduce mortality in patients with pancytopenia 8
    • One-year mortality rate is significantly higher in untreated HIV patients with pancytopenia (41.4% vs 5.2%) 8
  • Supportive care:

    • Erythropoietin for anemia 3
    • G-CSF or GM-CSF for neutropenia 2
    • Platelet transfusions for severe thrombocytopenia 2
  • Medication adjustments:

    • Consider switching from zidovudine to alternative agents 4
    • Avoid drugs with known bone marrow suppressive effects 4
    • Monitor for drug interactions that may worsen cytopenias 3

Special Considerations

  • Patients with advanced HIV disease (CD4 <200) are at highest risk for pancytopenia
  • Bone marrow failure may be prevented by reconstitution of the immune system 5
  • Type I interferon signaling plays a role in maintaining hematopoiesis during opportunistic infections 5
  • Empiric broad-spectrum antibiotics including staphylococcus prophylaxis should be initiated in febrile neutropenic patients until culture results are available 3

Understanding these various causes of pancytopenia in HIV-infected patients is crucial for appropriate management and improving outcomes in this vulnerable population.

References

Guideline

Viral Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Profile of HIV-Infected Hispanics with Pancytopenia.

International journal of environmental research and public health, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.